LECT2 and cancer: Loss of Lect2 fosters the accumulation/activation of M-MDSC, leading to the presence of M2-like TAMs and pro-tumorigenic cytokines (IL-4, IL-6, IL-10, and TGF-β) that can impair the activity of T cells in the fight against cancer.